10. FAIR VALUE MEASUREMENTS Fair Value Hierarchy Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e. the "exit price") in an orderly transaction between market participants. We use a fair value hierarchy that gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The hierarchy is broken down into three levels as follows: •Level 1 - Valuations based on unadjusted quoted prices in active markets that we have the ability to access for identical assets or liabilities. Valuation adjustments and block discounts are not applied to Level 1 instruments. •Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or significant inputs that are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data. •Level 3 - Valuations based on unobservable inputs where there is little or no market activity. Unadjusted third party pricing sources or management's assumptions and internal valuation models may be used to determine the fair values. In addition, certain of our other investments are measured at fair value using net asset value ("NAV") per share (or its equivalent) as a practical expedient and have not been classified within the fair value hierarchy as defined above. There have been no material changes in our valuation techniques during the period represented by these unaudited condensed consolidated financial statements. We have categorized our assets and liabilities that are recorded at fair value on a recurring and nonrecurring basis among levels based on the observability of inputs, or at fair value using NAV per share (or its equivalent) as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2025 | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Measured Using NAV as Practical Expedient | | Total Fair Value | | (in millions of U.S. dollars) | Investments: | | | | | | | | | | Short-term and fixed maturity investments: | | | | | | | | | | U.S. government and agency | $ | — | | | $ | 579 | | | $ | — | | | $ | — | | | $ | 579 | | U.K. government | — | | | 53 | | | — | | | — | | | 53 | | Other government | — | | | 364 | | | — | | | — | | | 364 | | Corporate | — | | | 3,414 | | | 13 | | | — | | | 3,427 | | Municipal | — | | | 105 | | | — | | | — | | | 105 | | Residential mortgage-backed | — | | | 444 | | | — | | | — | | | 444 | | Commercial mortgage-backed | — | | | 742 | | | — | | | — | | | 742 | | Asset-backed | — | | | 759 | | | 30 | | | — | | | 789 | | | | | | | | | | | | | | | | | | | | | | | $ | — | | | $ | 6,460 | | | $ | 43 | | | $ | — | | | $ | 6,503 | | | | | | | | | | | | Funds held (1) | $ | 70 | | | $ | 2,209 | | | $ | 4 | | | $ | 74 | | | $ | 2,357 | | Equities: | | | | | | | | | | Privately held equity investments | $ | — | | | $ | — | | | $ | 384 | | | $ | 71 | | | $ | 455 | | Publicly traded equity investments | 143 | | | 9 | | | 1 | | | — | | | 153 | | Exchange-traded funds | 135 | | | — | | | — | | | — | | | 135 | | Warrant and others | — | | | — | | | 16 | | | — | | | 16 | | | $ | 278 | | | $ | 9 | | | $ | 401 | | | $ | 71 | | | $ | 759 | | Other investments: | | | | | | | | | | | | | | | | | | | | Private equity funds | $ | — | | | $ | — | | | $ | — | | | $ | 1,949 | | | $ | 1,949 | | Private credit funds | — | | | 386 | | | — | | | 529 | | | 915 | | Hedge funds | — | | | — | | | — | | | 386 | | | 386 | | Fixed income funds | — | | | 5 | | | — | | | 370 | | | 375 | | Real estate fund | — | | | — | | | — | | | 427 | | | 427 | | CLO equity funds | — | | | — | | | — | | | 124 | | | 124 | | CLO equities | — | | | 25 | | | — | | | — | | | 25 | | Equity funds | — | | | 5 | | | — | | | — | | | 5 | | | | | | | | | | | | | $ | — | | | $ | 421 | | | $ | — | | | $ | 3,785 | | | $ | 4,206 | | Total Investments, excluding funds held by reinsured companies and equity method investments | $ | 348 | | | $ | 9,099 | | | $ | 448 | | | $ | 3,930 | | | $ | 13,825 | | | | | | | | | | | | | | | | | | | | | | Reinsurance balances recoverable on paid and unpaid losses: | $ | — | | | $ | — | | | $ | 194 | | | $ | — | | | $ | 194 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Assets: | | | | | | | | | | Derivatives qualifying as hedging | $ | — | | | $ | 1 | | | $ | — | | | $ | — | | | $ | 1 | | Derivatives not qualifying as hedging | — | | | 11 | | | — | | | — | | | 11 | | Derivative instruments | $ | — | | | $ | 12 | | | $ | — | | | $ | — | | | $ | 12 | | | | | | | | | | | | Losses and LAE: | $ | — | | | $ | — | | | $ | 996 | | | $ | — | | | $ | 996 | | | | | | | | | | | | Other Liabilities: | | | | | | | | | | Derivatives qualifying as hedging | $ | — | | | $ | 5 | | | $ | — | | | $ | — | | | $ | 5 | | Derivatives not qualifying as hedging | — | | | 3 | | | — | | | — | | | 3 | | Derivative instruments | $ | — | | | $ | 8 | | | $ | — | | | $ | — | | | $ | 8 | |
(1) The difference in the amount of funds held shown at fair value and the funds held shown in our unaudited condensed consolidated balance sheet relates to the $2.3 billion of funds held by reinsured companies carried at amortized cost as of March 31, 2025. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Measured Using NAV as Practical Expedient | | Total Fair Value | | | (in millions of U.S. dollars) | Investments: | | | | | | | | | | | Short-term and fixed maturity investments: | | | | | | | | | | | U.S. government and agency | | $ | — | | | $ | 420 | | | $ | — | | | $ | — | | | $ | 420 | | U.K government | | — | | | 44 | | | — | | | — | | | 44 | | Other government | | — | | | 359 | | | — | | | — | | | 359 | | Corporate | | — | | | 3,244 | | | 17 | | | — | | | 3,261 | | Municipal | | — | | | 109 | | | — | | | — | | | 109 | | Residential mortgage-backed | | — | | | 421 | | | — | | | — | | | 421 | | Commercial mortgage-backed | | — | | | 784 | | | — | | | — | | | 784 | | Asset-backed | | — | | | 742 | | | 30 | | | — | | | 772 | | | | | | | | | | | | | | | | | | | | | | | | | | — | | | 6,123 | | | 47 | | | — | | | 6,170 | | | | | | | | | | | | | Funds held (1) | | $ | 70 | | | $ | 2,305 | | | $ | 5 | | | $ | 71 | | | $ | 2,451 | | Equities: | | | | | | | | | | | Privately held equity investments | | $ | — | | | $ | — | | | $ | 389 | | | $ | 71 | | | $ | 460 | | Publicly traded equity investments | | 166 | | | 9 | | | 1 | | | — | | | 176 | | Exchange-traded funds | | 151 | | | — | | | — | | | — | | | 151 | | Warrant and others | | — | | | — | | | 16 | | | — | | | 16 | | | | $ | 317 | | | $ | 9 | | | $ | 406 | | | $ | 71 | | | $ | 803 | | Other investments: | | | | | | | | | | | Private equity funds | | $ | — | | | $ | — | | | $ | — | | | $ | 1,926 | | | $ | 1,926 | | Private credit funds | | — | | | 363 | | | — | | | 501 | | | 864 | | Hedge funds | | — | | | — | | | — | | | 410 | | | 410 | | Real estate funds | | — | | | — | | | — | | | 401 | | | 401 | | Fixed income funds | | — | | | 5 | | | — | | | 364 | | | 369 | | CLO equity funds | | — | | | — | | | — | | | 162 | | | 162 | | CLO equities | | — | | | 52 | | | — | | | — | | | 52 | | Equity funds | | — | | | 4 | | | — | | | — | | | 4 | | | | | | | | | | | | | | | $ | — | | | $ | 424 | | | $ | — | | | $ | 3,764 | | | $ | 4,188 | | Total Investments, excluding funds held by reinsured companies and equity method investments | | $ | 387 | | | $ | 8,861 | | | $ | 458 | | | $ | 3,906 | | | $ | 13,612 | | | | | | | | | | | | | | | | | | | | | | | | Reinsurance balances recoverable on paid and unpaid losses: | | $ | — | | | $ | — | | | $ | 179 | | | $ | — | | | $ | 179 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Assets: | | | | | | | | | | | Derivatives qualifying as hedging | | $ | — | | | $ | 2 | | | $ | — | | | $ | — | | | $ | 2 | | Derivatives not qualifying as hedging | | — | | | 3 | | | — | | | — | | | 3 | | Derivative instruments | | $ | — | | | $ | 5 | | | $ | — | | | $ | — | | | $ | 5 | | | | | | | | | | | | | Losses and LAE: | | $ | — | | | $ | — | | | $ | 997 | | | $ | — | | | $ | 997 | | | | | | | | | | | | | Other Liabilities: | | | | | | | | | | | | | | | | | | | | | | Derivatives not qualifying as hedging | | $ | — | | | $ | 7 | | | $ | — | | | $ | — | | | $ | 7 | | | | | | | | | | | | |
(1) The difference in the amount of funds held shown at fair value and the funds held shown in our consolidated balance sheet relates to the $2.5 billion of funds held by reinsured companies carried at amortized cost as of December 31, 2024. Level 3 Measurements and Changes in Leveling Transfers into or out of levels are recorded at their fair values as of the end of the reporting period, consistent with the date of determination of fair value. Investments The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | March 31, 2025 | | | | | Fixed maturity investments | | Equities | | Total | | | | | Corporate | | | | | | Asset-backed | | Privately-held Equities | | Public Equities | | Warrants and Other | | | | | (in millions of U.S. dollars) | Beginning fair value | | $ | 17 | | | | | | | $ | 30 | | | $ | 389 | | | $ | 1 | | | $ | 16 | | | $ | 453 | | | | | | | | | | | | | | | | | | | | | | | Sales and paydowns | | (5) | | | | | | | — | | | — | | | — | | | — | | | (5) | | | | Total fair value changes in trading securities, funds held and other investments (1) | | 1 | | | | | | | — | | | (5) | | | — | | | — | | | (4) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Ending fair value | | $ | 13 | | | | | | | $ | 30 | | | $ | 384 | | | $ | 1 | | | $ | 16 | | | $ | 444 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | March 31, 2024 | | | | Fixed maturity investments | | Equities | | Total | | | | Corporate | | | | | | Asset-backed | | Privately-held Equities | | Public Equities | | | | | | | (in millions of U.S. dollars) | Beginning fair value | | $ | 12 | | | | | | | $ | 11 | | | $ | 299 | | | $ | 1 | | | | | $ | 323 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total fair value changes in trading securities, funds held and other investments (1) | | — | | | | | | | — | | | (2) | | | — | | | | | (2) | | | Transfer into Level 3 from Level 2 | | 5 | | | | | | | 15 | | | — | | | — | | | | | 20 | | | | | | | | | | | | | | | | | | | | | Ending fair value | | $ | 17 | | | | | | | $ | 26 | | | $ | 297 | | | $ | 1 | | | | | $ | 341 | | |
(1) Fair value changes in trading securities, funds held and other investments included in our consolidated statements of operations is equal to the change in fair value changes in trading securities, funds held and other investments relating to assets held at the end of the reporting period. Fair value changes in trading securities, funds held and other investments related to Level 3 assets in the tables above are included in fair value changes in trading securities, funds held and other investments in our consolidated statements of operations. Transfers into Level 3 are primarily attributable to the lack of observable market transactions and price information and the use of unobservable inputs within valuation methodologies. Valuation Techniques and Inputs The table below presents the quantitative information related to the fair value measurements for our fixed maturity and equity investments measured at fair value on a recurring and non-recurring basis using Level 3 inputs:
| | | | | | | | | | | | | | | | | | | | | | | Qualitative Information about Level 3 Fair Value Measurements | Valuation Techniques | | Fair Value as of March 31, 2025 | | | | Unobservable Input | | Range (Average) (1) | | | (in millions of U.S. dollars) | | | | | | | Recurring basis: | | | | | | | | | | | | | | | | | | Fixed maturities | | | | | | | | | Corporate | | | | | | | | | Discounted cash flow | | $ | 13 | | | | | YTM; implied total yield | | 6.04% - 9.65% | Asset-backed | | | | | | | | | Discounted cash flow | | 30 | | | | YTM | | 6.32% - 9.41% | Total fixed maturities | | $ | 43 | | | | | | | | | | | | | | | | | Equity investments | | | | | | | | | Privately held equity investments | | | | | | | | | | | | | | | | | | Guideline company methodology; Option pricing model | | $ | 220 | | | | | P/BV multiple P/BV (excluding AOCI) multiple Expected term | | 1.3x - 1.8x 1.3x -1.7x 1-3 years | Guideline companies method | | 67 | | | | | P/BV multiple Price/2025 earnings | | 1.6x - 1.7x 8x - 9.5x | Guideline companies method | | 36 | | | | | LTM Enterprise Value/ EBITDA multiples | | 14.5x - 15.9x | Earnings | | 4 | | | | | Multiple on earnings | | 5x | Dividend discount model | | 56 | | | | | Discount rate | | 7.4% | | | 383 | | | | | | | | | | | | | | | | | Publicly traded equity investments | | | | | | | | | Discounted cash flow | | 1 | | | | | Implied total yield | | 8.50% | | | | | | | | | | Warrants and Other | | | | | | | | | Black-Scholes model | | 16 | | | | | Expected term in years | | 9.5 years | Total recurring equity Investments | | $ | 400 | | | | | | | | | | | | | | | | | Non-recurring basis: | | | | | | | | | | | | | | | | | | Privately held equity investments | | | | | | | | | Cost as approximation of fair value | | $ | 1 | | | | | Cost as approximation of fair value | | | | | | | | | | | | Total Recurring and Non-recurring equity investments | | $ | 401 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) The average represents the arithmetic average of the inputs and is not weighted by the relative fair value. Funds Held by Reinsured Companies - Embedded Derivative As described in Note 5, we have an embedded derivative in relation to the Aspen LPT transaction to account for the fair value of the full crediting rate we expect to earn on the funds withheld received as consideration. The following table presents a reconciliation of the beginning and ending balances for the embedded derivative measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | 2025 | | 2024 | | | | | | (in millions of U.S. dollars) | Beginning fair value | $ | 5 | | | $ | 40 | | | | | | | | | | | | | | Total fair value changes | (1) | | | (18) | | | | | | | | | | | | | | Ending fair value | $ | 4 | | | $ | 22 | | | | | |
Fair value changes in trading securities, funds held and other investments in the table above are included in fair value changes in trading securities, funds held and other investments in our unaudited condensed consolidated statements of operations. Valuations Techniques and Inputs The table below presents the qualitative information related to the fair value measurements for the embedded derivative on our funds held by reinsured companies measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | | | | | Qualitative Information about Level 3 Fair Value Measurements | Valuation Techniques | | Fair Value as of March 31, 2025 | | Unobservable Input | | Average | | | (in millions of U.S. dollars) | | | | | Monte Carlo simulation model; Discounted cash flow analysis | | $ | 4 | | | Volatility rate; Expected Loss Payments | | 3.46% $210 million | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | 2025 | | 2024 | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | (in millions of U.S. dollars) | Beginning fair value | $ | 997 | | | $ | 183 | | | $ | 814 | | | $ | 1,163 | | | $ | 217 | | | $ | 946 | | | | | | | | | | | | | | Incurred losses and LAE: | | | | | | | | | | | | (Reduction) increase in estimates of ultimate losses | (2) | | | 1 | | | (3) | | | (6) | | | (9) | | | 3 | | Reduction in unallocated LAE | (1) | | | — | | | (1) | | | (2) | | | — | | | (2) | | Change in fair value due to changes in : | | | | | | | | | | | | Average payout | 9 | | | 1 | | | 8 | | | 10 | | | 2 | | | 8 | | Corporate bond yield | (3) | | | — | | | (3) | | | (16) | | | (3) | | | (13) | | Risk cost of capital | — | | | — | | | — | | | 1 | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | | | | | | | Total change in fair value | 6 | | | 1 | | | 5 | | | (5) | | | (1) | | | (4) | | Total incurred losses and LAE | 3 | | | 2 | | | 1 | | | (13) | | | (10) | | | (3) | | Paid losses | (26) | | | 6 | | | (32) | | | (39) | | | (6) | | | (33) | | | | | | | | | | | | | | Effect of exchange rate movements | 22 | | | 3 | | | 19 | | | (13) | | | 6 | | | (19) | | Ending fair value | $ | 996 | | | $ | 194 | | | $ | 802 | | | $ | 1,098 | | | $ | 207 | | | $ | 891 | |
Below is a summary of the quantitative information regarding the significant observable and unobservable inputs used in the internal model to determine fair value on a recurring basis: | | | | | | | | | | | | | | | Valuation Technique | | March 31, 2025 | | December 31, 2024 | Unobservable (U) and Observable (O) Inputs | Weighted Average | Internal model | Corporate bond yield (O) | A Rated | | A Rated | Internal model | Credit spread for Instrument-specific credit risk (U) | 0.40% | | 0.40% | Internal model | Risk cost of capital (U) | 6.15% | | 6.15% | Internal model | Weighted average cost of capital (U) | 9.25% | | 9.25% | Internal model | Average payout - liability (U) | 8.01 years | | 8.10 years | Internal model | Average payout - reinsurance balances recoverable on paid and unpaid losses (U) | 8.04 years | | 8.39 years |
The fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses may increase or decrease due to changes in the corporate bond rate, the credit spread for non-performance risk, the risk cost of capital, the weighted average cost of capital and the estimated payment pattern. In addition, the estimate of the capital required to support the liabilities is based upon current industry standards for capital adequacy. Changes in the fair value due to changes in average payout and corporate bond yields are included in net incurred losses and loss adjustment expenses in our unaudited condensed consolidated statements of operations. Changes in the fair value due to changes in credit spread for Instrument-specific credit risk are classified to other comprehensive income. Disclosure of Fair Values for Financial Instruments Carried at Cost Senior and Junior Subordinated Notes The following table presents the fair values of our Senior and Junior Subordinated Notes carried at amortized cost: | | | | | | | | | | | | | | | | | March 31, 2025 | | | Amortized Cost | | Fair Value | | | (in millions of U.S. dollars) | 4.95% Senior Notes due 2029 | | $ | 497 | | | $ | 498 | | 3.10% Senior Notes due 2031 | | 496 | | | 432 | | Total Senior Notes | | $ | 993 | | | $ | 930 | | 5.75% Junior Subordinated Notes due 2040 | | $ | 116 | | | $ | 117 | | 5.50% Junior Subordinated Notes due 2042 | | 494 | | | 487 | | 7.50% Junior Subordinated Notes due 2045 | | 345 | | | 355 | | | | | | | Total Junior Subordinated Notes | | $ | 955 | | | $ | 959 | | Total debt | | $ | 1,948 | | | $ | 1,889 | |
The fair value of our Senior Notes and our Junior Subordinated Notes was based on observable market pricing from a third-party pricing service. Both the Senior Notes and Junior Subordinated Notes are classified as Level 2. Insurance Contracts Disclosure of fair value of amounts relating to insurance contracts is not required, except those for which we elected the fair value option, as described above. Remaining Financial Assets and Liabilities Our remaining financial assets and liabilities were generally carried at cost or amortized cost, which due to their short-term nature approximates fair value as of March 31, 2025 and December 31, 2024.
|